for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Malaysia secures 18.4 mln doses of Russian, Chinese COVID-19 vaccines

KUALA LUMPUR, Jan 26 (Reuters) - Malaysia on Tuesday struck deals with two domestic companies to purchase 18.4 million doses of COVID-19 vaccines produced by Russia’s Gamaleya Institute and China’s Sinovac, the health ministry said.

Malaysian pharmaceutical firm Duopharma will supply the government with 6.4 million doses of Gamaleya’s Sputnik V vaccine, the ministry said in a statement. It said Malaysia Pharmaniaga Berhad will supply 12 million doses of Sinovac’s vaccine. (Reporting by Rozanna Latiff and Joseph Sipalan; Editing by Martin Petty)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up